![Frontiers | Liquid Biopsy in Malignant Pleural Mesothelioma: State of the Art, Pitfalls, and Perspectives Frontiers | Liquid Biopsy in Malignant Pleural Mesothelioma: State of the Art, Pitfalls, and Perspectives](https://www.frontiersin.org/files/MyHome%20Article%20Library/473695/473695_Thumb_400.jpg)
Frontiers | Liquid Biopsy in Malignant Pleural Mesothelioma: State of the Art, Pitfalls, and Perspectives
![Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis | European Respiratory Society Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis | European Respiratory Society](https://err.ersjournals.com/content/errev/30/162/210057/F4.large.jpg)
Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis | European Respiratory Society
![Guidelines for the diagnosis and treatment of malignant pleural mesothelioma - van Zandwijk - Journal of Thoracic Disease Guidelines for the diagnosis and treatment of malignant pleural mesothelioma - van Zandwijk - Journal of Thoracic Disease](https://cdn.amegroups.cn/journals/pbpc/files/journals/2/articles/1903/public/1903-PB18-R1.png/w300)
Guidelines for the diagnosis and treatment of malignant pleural mesothelioma - van Zandwijk - Journal of Thoracic Disease
![Identification of Novel Markers for the Diagnosis of Malignant Pleural Mesothelioma - The American Journal of Pathology Identification of Novel Markers for the Diagnosis of Malignant Pleural Mesothelioma - The American Journal of Pathology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2000872955/2002850315/gr1.jpg)
Identification of Novel Markers for the Diagnosis of Malignant Pleural Mesothelioma - The American Journal of Pathology
![Table 2 from Molecular profiling of malignant pleural mesothelioma and pulmonary fibrosis | Semantic Scholar Table 2 from Molecular profiling of malignant pleural mesothelioma and pulmonary fibrosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/fa8c49933a3a0d221da7a7f320dffaea1ef095b5/26-Table2-1.png)
Table 2 from Molecular profiling of malignant pleural mesothelioma and pulmonary fibrosis | Semantic Scholar
![Frontiers | The Use of Immunohistochemistry, Fluorescence in situ Hybridization, and Emerging Epigenetic Markers in the Diagnosis of Malignant Pleural Mesothelioma (MPM): A Review Frontiers | The Use of Immunohistochemistry, Fluorescence in situ Hybridization, and Emerging Epigenetic Markers in the Diagnosis of Malignant Pleural Mesothelioma (MPM): A Review](https://www.frontiersin.org/files/Articles/523977/fonc-10-01742-HTML/image_m/fonc-10-01742-g001.jpg)
Frontiers | The Use of Immunohistochemistry, Fluorescence in situ Hybridization, and Emerging Epigenetic Markers in the Diagnosis of Malignant Pleural Mesothelioma (MPM): A Review
![Frontiers | The Use of Immunohistochemistry, Fluorescence in situ Hybridization, and Emerging Epigenetic Markers in the Diagnosis of Malignant Pleural Mesothelioma (MPM): A Review Frontiers | The Use of Immunohistochemistry, Fluorescence in situ Hybridization, and Emerging Epigenetic Markers in the Diagnosis of Malignant Pleural Mesothelioma (MPM): A Review](https://www.frontiersin.org/files/Articles/523977/fonc-10-01742-HTML/image_m/fonc-10-01742-t002.jpg)
Frontiers | The Use of Immunohistochemistry, Fluorescence in situ Hybridization, and Emerging Epigenetic Markers in the Diagnosis of Malignant Pleural Mesothelioma (MPM): A Review
![The Use of Immunohistochemistry, Fluorescence in situ Hybridization, and Emerging Epigenetic Markers in the Diagnosis of Malignant Pleural Mesothelioma (MPM): A Review | Semantic Scholar The Use of Immunohistochemistry, Fluorescence in situ Hybridization, and Emerging Epigenetic Markers in the Diagnosis of Malignant Pleural Mesothelioma (MPM): A Review | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/25cc47fecebd5e895d8234a5d668656af018f328/4-Table3-1.png)
The Use of Immunohistochemistry, Fluorescence in situ Hybridization, and Emerging Epigenetic Markers in the Diagnosis of Malignant Pleural Mesothelioma (MPM): A Review | Semantic Scholar
![Cancers | Free Full-Text | Malignant Pleural Mesothelioma: Genetic and Microenviromental Heterogeneity as an Unexpected Reading Frame and Therapeutic Challenge | HTML Cancers | Free Full-Text | Malignant Pleural Mesothelioma: Genetic and Microenviromental Heterogeneity as an Unexpected Reading Frame and Therapeutic Challenge | HTML](https://www.mdpi.com/cancers/cancers-12-01186/article_deploy/html/images/cancers-12-01186-g001-550.jpg)
Cancers | Free Full-Text | Malignant Pleural Mesothelioma: Genetic and Microenviromental Heterogeneity as an Unexpected Reading Frame and Therapeutic Challenge | HTML
![Frequent expression of conventional endothelial markers in pleural mesothelioma: usefulness of claudin-5 as well as combined traditional markers to distinguish mesothelioma from angiosarcoma - Lung Cancer Frequent expression of conventional endothelial markers in pleural mesothelioma: usefulness of claudin-5 as well as combined traditional markers to distinguish mesothelioma from angiosarcoma - Lung Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d6e5937c-d5af-4790-bcde-365acf0054e5/gr1.jpg)
Frequent expression of conventional endothelial markers in pleural mesothelioma: usefulness of claudin-5 as well as combined traditional markers to distinguish mesothelioma from angiosarcoma - Lung Cancer
![Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions - eBioMedicine Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions - eBioMedicine](https://www.thelancet.com/cms/attachment/27e82f77-8a9f-4b38-83be-877ace7caf72/gr4.jpg)
Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions - eBioMedicine
![Quantitative mass spectrometry to identify protein markers for diagnosis of malignant pleural mesothelioma - ScienceDirect Quantitative mass spectrometry to identify protein markers for diagnosis of malignant pleural mesothelioma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1874391918303592-ga1.jpg)
Quantitative mass spectrometry to identify protein markers for diagnosis of malignant pleural mesothelioma - ScienceDirect
![Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis | European Respiratory Society Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis | European Respiratory Society](https://err.ersjournals.com/content/errev/30/162/210057/F1.large.jpg)
Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis | European Respiratory Society
![Frontiers | The Use of Immunohistochemistry, Fluorescence in situ Hybridization, and Emerging Epigenetic Markers in the Diagnosis of Malignant Pleural Mesothelioma (MPM): A Review Frontiers | The Use of Immunohistochemistry, Fluorescence in situ Hybridization, and Emerging Epigenetic Markers in the Diagnosis of Malignant Pleural Mesothelioma (MPM): A Review](https://www.frontiersin.org/files/Articles/523977/fonc-10-01742-HTML/image_m/fonc-10-01742-t001.jpg)
Frontiers | The Use of Immunohistochemistry, Fluorescence in situ Hybridization, and Emerging Epigenetic Markers in the Diagnosis of Malignant Pleural Mesothelioma (MPM): A Review
![Genetics of malignant pleural mesothelioma: molecular markers and biologic targets - Thoracic Surgery Clinics Genetics of malignant pleural mesothelioma: molecular markers and biologic targets - Thoracic Surgery Clinics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2003816724/2014945354/gr1.gif)
Genetics of malignant pleural mesothelioma: molecular markers and biologic targets - Thoracic Surgery Clinics
![Ki67 (MIB-1) as a Prognostic Marker for Clinical Decision Making Before Extended Pleurectomy Decortication in Malignant Pleural Mesothelioma - JTO Clinical and Research Reports Ki67 (MIB-1) as a Prognostic Marker for Clinical Decision Making Before Extended Pleurectomy Decortication in Malignant Pleural Mesothelioma - JTO Clinical and Research Reports](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/0d4e5b3a-b5e6-46b4-9d3c-947b80543312/gr1.jpg)
Ki67 (MIB-1) as a Prognostic Marker for Clinical Decision Making Before Extended Pleurectomy Decortication in Malignant Pleural Mesothelioma - JTO Clinical and Research Reports
![Megakaryocyte potentiating factor as a tumor marker of malignant pleural mesothelioma: Evaluation in comparison with mesothelin - Lung Cancer Megakaryocyte potentiating factor as a tumor marker of malignant pleural mesothelioma: Evaluation in comparison with mesothelin - Lung Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/85ac634a-9ac1-433d-b95b-fbf9307f5783/gr1_lrg.jpg)